Ülke: Birleşik Krallık
Dil: İngilizce
Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)
Hydrocortisone acetate
Advanz Pharma
H02AB09
Hydrocortisone acetate
25mg/1ml
Suspension for injection
Intraarticular; Periarticular
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010202; GTIN: 5060064170694
OBJECT 1 HYDROCORTISTAB INJECTION 25 MG/ML Summary of Product Characteristics Updated 07-Aug-2017 | Concordia International - formerly AMCo 1. Name of the medicinal product Hydrocortistab Injection Hydrocortisone Acetate 25mg/ml Suspension for Injection 2. Qualitative and quantitative composition Hydrocortisone Acetate Ph Eur 2.5% w/v (25 mg/ml). 3. Pharmaceutical form Suspension for injection. 4. Clinical particulars 4.1 Therapeutic indications This medicine is indicated for the local treatment, by intra-articular or periarticular injection, of arthritic conditions such as rheumatoid arthritis and osteoarthritis when few joints are involved. It is also suitable for the symptomatic treatment, by local injection, of certain non-articular inflammatory conditions such as inflamed tendon sheaths and bursae. This medicine is not suitable for the production of systemic effects. 4.2 Posology and method of administration For intra-articular or periarticular injection. This medicine may also be injected into non-articular tissues (e.g. tendon sheaths/bursae). Adults: 5-50 mg, depending on the size of the joint. Children: 5-30 mg daily in divided doses. Elderly: Steroids should be used cautiously in the elderly, since adverse effects are enhanced in old age. No more than three joints should be treated in one day. The injection may be repeated at intervals of about three weeks. 4.3 Contraindications This medicine is contra-indicated in patients with known hypersensitivity to any of the ingredients. It is also contraindicated in patients with systemic infections (unless specific anti-infective therapy is employed) and in patients vaccinated with live vaccines. Intra-articular and periarticular injections of this medicine is contra-indicated when the joint or surrounding tissues are infected. The presence of infection also precludes injection into tendon sheaths and bursae. This medicine must not be injected directly into tendons, nor should it be injected into spinal or other non-diarthrodial joints. 4.4 Special warnings and Belgenin tamamını okuyun